![]() |
Acta Pharmacologica Sinica (2010) 31: 805–812; doi: 10.1038/aps.2010.65; published online 28 June 2010 |
| Original Article | [ Full text ] |
| Activation of the ERK signaling pathway is involved in CD151-induced angiogenic effects on the formation of CD151-integrin complexes |
Hou-juan ZUO#, Jing-yang LIN#, $, Zhao-yu LIU, Wei-feng LIU, Tao LIU, Jun YANG, Yu LIU, Dao-wen WANG, Zheng-xiang LIU* Department of Cardiology of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
|
Results: CD151 gene delivery increased the expression of CD151 at both the mRNA and protein levels. Overexpression of CD151 promoted cell proliferation, migration and tube formation in vitro, and phosphorylation of ERK was also increased. Further, CD151-induced cell proliferation, migration, and tube formation were attenuated by the ERK inhibitor PD98059 (20 µmol/L) but not by a p38 inhibitor (SB203580, 20 µmol/L). Moreover, there was no significant difference in CD151 protein expression between the CD151 group and the CD151-AAA group, but the CD151-AAA mutant abrogated cellular proliferation, migration, and tube formation and decreased the phosphorylation of ERK.
Conclusion: This study suggests that activation of the ERK signaling
pathway may be involved in the angiogenic effects of
CD151. Activation of ERK was
dependent on the formation of CD151-integrin complexes. Therefore modulation of CD151 may be as
a novel therapeutic strategy for regulating angiogenesis.
Keywords: CD151; cell migration; cell proliferation; angiogenesis; ERK; p38 MAPK; human umbilical vein endothelial cells |
The project was supported by a grant from the National Natural Science Foundation of China (No 30670856). We are grateful to Dr Xin ZHANG for providing the PzeoSV-CD151 plasmid (Department of Molecular Science, University of Tennessee Health Science Center). |
| # These two authors contributed equally to this work. $ Now in Department of Cardiology of Zhejiang Provincial People’s Hospital, Hangzhou China * To whom correspondence should be addressed. E-mail liuzhengxiang@hotmail.com Received |
[ Full text ] |
Copyright©APS 2010 Add: 294 Tai-Yuan Road, Shanghai 200031, China Phn: 86-21-5492-2821 Fax: 86-21-5492-2823 E-mail: aps@mail.shcnc.ac.cn |